Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
268 studies found for:    Amyotrophic Lateral Sclerosis (ALS)
Show Display Options
Download search resultsDownload the search results for:
Amyotrophic Lateral Sclerosis (ALS) (268 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Terminated
Has Results
Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Lithium Carbonate;   Drug: Riluzole;   Drug: placebo
2 Recruiting Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Placebo (for MN-166);   Drug: MN-166
3 Recruiting Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Procedure: ALS Patients receiving stem cells;   Procedure: ALS patients not receiving stem cells
4 Unknown  Far Infrared Irradiation for Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Radiation: Far Infrared Radiation (5μm to 20μm wavelength);   Radiation: Far infrared radiation
5 Recruiting The National Amyotrophic Lateral Sclerosis Registry
Condition: Amyotrophic Lateral Sclerosis
Intervention:
6 Active, not recruiting Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis
Conditions: Amyotrophic Lateral Sclerosis 1;   Acquired Amyotrophic Lateral Sclerosis;   Amyotrophic Lateral Sclerosis
Intervention: Drug: Arimoclomol
7 Active, not recruiting Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Ozanezumab;   Drug: Placebo
8 Active, not recruiting Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Device: surgical implantation
9 Unknown  Efficacy and Tolerability of Tauroursodeoxycholic Acid in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: tauroursodeoxycholic acid (TUDCA);   Drug: Placebo
10 Active, not recruiting Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: Basiliximab;   Drug: Methylprednisolone;   Drug: Prednisone;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil
11 Recruiting Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Rasagiline;   Drug: Placebo
12 Completed
Has Results
Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Insulin like growth factor, type 1;   Drug: Placebo
13 Recruiting Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Other: MRI + 18FDG-PET + neuropsychological assessments ; 18FDG performed especially for the research
14 Completed Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: SB-509
15 Terminated Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).
Conditions: Amyotrophic Lateral Sclerosis;   Neurodegenerative Disease;   Motor Neuron Disease
Intervention:
16 Unknown  Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: Creatine Monohydrate
17 Active, not recruiting Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: MCI-186;   Drug: Placebo;   Drug: MCI-186 in open label phase
18 Suspended Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: autologous bone marrow-derived stem cells
19 Unknown  Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)
Conditions: ALS;   Amyotrophic Lateral Sclerosis
Intervention:
20 Recruiting Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea
Conditions: Sialorrhea;   Amyotrophic Lateral Sclerosis
Interventions: Drug: Botox injection;   Drug: Placebo injection

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years